FABP4 and Obesity: While elevated FABP4 has been well demonstrated in obesity, the metabolic syndrome, and type 2 diabetes and likely contributes to the well-documented insulin resistance in these pathological conditions, to the best of our knowledge this is the first report demonstrating an important physiological role of this adipokine.